<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>207(6)</volume><submitter>Salvino MA</submitter><funding>Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, USA</funding><journal>British journal of haematology</journal><pagination>2583-2587</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12710109</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma.</pubmed_title><pmcid>PMC12710109</pmcid><pubmed_authors>Kobayashi R</pubmed_authors><pubmed_authors>Zecca M</pubmed_authors><pubmed_authors>Salvino MA</pubmed_authors><pubmed_authors>Locatelli F</pubmed_authors><pubmed_authors>Luisi FAV</pubmed_authors><pubmed_authors>Sidi Y</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Bai X</pubmed_authors><pubmed_authors>Pianovski MA</pubmed_authors><pubmed_authors>Fagioli F</pubmed_authors><pubmed_authors>Koga Y</pubmed_authors><pubmed_authors>Filho VO</pubmed_authors><pubmed_authors>Lima LBA</pubmed_authors><pubmed_authors>Campana F</pubmed_authors><pubmed_authors>Bush R</pubmed_authors><pubmed_authors>Epelman S</pubmed_authors><pubmed_authors>Favre C</pubmed_authors></additional><is_claimable>false</is_claimable><name>A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-04T03:21:30.992Z</modification><creation>2026-07-04T03:12:19.825Z</creation></dates><accession>S-EPMC12710109</accession><cross_references><pubmed>41084939</pubmed><doi>10.1111/bjh.70207</doi></cross_references></HashMap>